
Longevity Science investigates the biological mechanisms underlying aging and age-related decline, focusing on cellular senescence, telomere dynamics, epigenetic alterations, mitochondrial function, and systemic inflammation. This multidisciplinary field integrates molecular biology, genetics, pharmacology, and bioinformatics to identify interventions that extend healthspan and lifespan. Research spans senolytic compounds, caloric restriction mimetics, stem cell therapies, and epigenetic reprogramming, aiming to delay or reverse physiological deterioration. The following compilation presents the latest peer-reviewed publications and patents, reflecting advances in biomarkers of aging, geroprotective agents, and translational approaches targeting fundamental aging processes.
This is our latest selection of worldwide publications and patents in english on Longevity Science, between many scientific online journals, classified and focused on senescence, telomere, longevity science, caloric restriction, autophagy, mitochondrial dysfunction, epigenetic clock, geroprotector, senolytic, stemcell therapy, oxidative stress, dna repair, proteostasis, inflammaging, mTOR inhibition, sirtuin, longevity gene, metformin, rapamycin, cellular reprogramming, age-related disease, biomarker sofaging, nutraceutical, lifespan extension, health span, telomerase activation, circadian rhythm, glycation, neurodegeneration, hormesis and epigenetics.
Lactiplantibacillus plantarum strain and uses thereof
Patent published on the 2026-10-15 in WO under Ref WO2026215198 by CENTRO NAC DE TECNOLOGIA Y SEGURIDAD ALIMENTARIA [ES] (Aranaz Oroz Paula [es], GonzÁlez Navarro Carlos Javier [es], Goyache Sarasa Ignacio [es], Milagro Yoldi FermÍn I [es], Rodas MÉndez Ana Lucia [es], Virto Resano Raquel [es], ValdÉs Varela Lorena [es])
Abstract: The present invention relates a new probiotic strain of the species Lactiplantibacillus plantarum deposited at the "Colección Española de Cultivos Tipo (CECT)" under the accession number CECT 30972, or a variant of said strain, to compositions, pharmaceutical compositions or food products comprising said strain, and uses thereof in the prevention and/or treatment of obesity and associated metabolic diseases, inflammation, oxidative stress and fatty liver disease. The present invention also rel[...]
Our summary: The invention describes a new probiotic strain of Lactiplantibacillus plantarum with potential health benefits. It can be used in compositions for preventing or treating obesity and related metabolic disorders. Additionally, it includes various formulations like bacterial cultures and postbiotic compositions.
Lactiplantibacillus plantarum, probiotic strain, obesity treatment, metabolic diseases
Patent
Cosmetic product for modulating the microbiome and managing oxidative stress in the oral cavity, and its use
Patent published on the 2026-10-14 in SK under Ref SK2852025U by VIVAX PHARMACEUTICALS S R O [SK] (Čiko Bronislav [sk])
Abstract: Compositions for modulating the oral microbiome and managing oral oxidative stress are described. The compositions contain resveratrol, epigallocatechin gallate (EGCG), curcumin, polyphenols, and zeolite as active ingredients. The compositions may be in the form of a gel, paste, cream, mouthwash, lozenge, or chewing gum.[...]
Our summary: This cosmetic product targets the oral microbiome and oxidative stress. It includes resveratrol, EGCG, curcumin, polyphenols, and zeolite. The formulations can be delivered as gels, pastes, creams, mouthwashes, lozenges, or chewing gums.
microbiome modulation, oxidative stress management, oral health, active ingredients
Patent
Sulfurized imidazoles in ophthalmic formulations
Patent published on the 2026-10-08 in US under Ref US20260306457 by GENEIII BIOTECH CO LTD [CN] (Wang Cai Rong [us], Ding Wei [us])
Abstract: In the embodiments, ophthalmic formulations comprise 0.001-2% (w/v) of L-Ergothioneine or derivatives of L-Ergothioneine, optionally combined with compatible toxicity agents. L-ergothioneine or derivatives of L-Ergothioneine in the ophthalmic formulation is: an active pharmaceutical ingredient (API) for treating oxidative stress-related ocular disorders; and an inactive excipient for use as a stabilizing excipient to enhance bioavailability and prolong shelf-life of co-administered APIs. L-ergot[...]
Our summary: Sulfurized imidazoles are used in ophthalmic formulations containing L-Ergothioneine. These formulations enhance bioavailability and shelf-life of active pharmaceutical ingredients. L-Ergothioneine improves corneal permeability and provides synergistic effects with neuroprotective agents.
Sulfurized imidazoles, L-Ergothioneine, ophthalmic formulations, oxidative stress
Patent
A continuous enzymatic process for producing oligosaccharides from agricultural waste and low-value biomass streams
Patent published on the 2026-10-07 in IE under Ref IE20250488 by JOHN O HALLORAN [IE] (John O' Halloran [ie])
Abstract: The present invention relates to a method for the continuous and cost-effective production of nutraceutical oligosaccharides from agricultural waste and low-value biomass streams. The method comprises pre-treating biomass to break down the fibre matrix and separate hemicellulose, followed by purification to remove impurities. The purified hemicellulose is hydrolysed in an enzymatic membrane reactor using specific hemicellulases under controlled pH and temperature. Ultrafiltration is employed to [...]
Our summary: The invention describes a continuous method for producing nutraceutical oligosaccharides from agricultural waste. It involves pre-treating biomass to separate hemicellulose, followed by enzymatic hydrolysis and purification. The process utilizes specific enzymes and ultrafiltration to enhance efficiency and recycle components.
enzymatic process, oligosaccharides, agricultural waste, hemicellulose
Patent
Shenmai formula compound preparation for treating type ii diabetes
Patent published on the 2026-09-30 in ZA under Ref ZA202600064 by NINGBO POLYTECHNIC UNIV [CN] (Liu Xingyan [cn], Liu Peng [cn], Liu Yating [cn], Du Mengling [cn], Lou Jia [cn])
Abstract: The present invention discloses a Shenmai formula compound preparation for treating Type II diabetes, belonging to the field of biomedicine. The invention uses red ginseng, Ophiopogon japonicus, Bletilla striata, Leonurus japonicus, Myrrh, Saposhnikovia divaricata, and Codonopsis pilosula as raw materials for the pharmaceutical composition. Through soaking, decocting, and filtering, a Shenmai formula compound preparation for treating Type II diabetes is prepared. Experimental results show that a[...]
Our summary: The Shenmai formula compound preparation is designed to treat Type II diabetes using various herbal ingredients. Experimental results indicate significant reductions in fasting blood glucose levels in hyperglycemic model mice. This preparation shows comparable efficacy to metformin and presents a promising option for diabetes treatment.
Shenmai formula, Type II diabetes, biomedicine, hypoglycemic efficacy
Patent
Vaporization device for use in the administration by inhalation of a liquid comprising at least one active ingredient
Patent published on the 2026-09-30 in EP under Ref EP4813426 by GERVASONI CRISTINA [IT] (Gervasoni Cristina [it])
Abstract: [0001] A device (1;20) for the vaporization and the administration by inhalation of a liquid is described, the device comprising: - a tank containing a liquid to be vaporized, said liquid comprising at least one therapeutic, nutraceutical, food-supplement, phytotherapeutic, aromatherapeutic, cosmetic or general-wellness active ingredient or said liquid being a liquid classified as a medical device, - a vaporization unit comprising a heating element or an ultrasonic transducer to vaporize said li[...]
Our summary: The device is designed for vaporizing and administering liquids containing active ingredients through inhalation. It features a tank, a vaporization unit with a heating element or ultrasonic transducer, and a mouthpiece. The command-and-control unit regulates the temperature or power of the vaporization process.
vaporization, inhalation, active ingredient, device
Patent
From history to emerging frontiers
Published on 2026-09-15 by @MIT
Abstract: AbstractDiffusion MRI transformed brain imaging by making MRI sensitive not only to anatomy and spin-relaxation contrast, but also to micrometer-scale water displacements over diffusion times of a few tens of milliseconds. The resulting signal is exquisitely sensitive to tissue organization, because cell membranes, myelin, axonal packing, orientation dispersion, exchange, as well as perfusion-related incoherent fluid motion all modulate the displacement distribution sampled by diffusing water mo[...]
Our summary: Diffusion MRI revolutionized brain imaging by enabling detection of acute ischemia before conventional imaging. It allows for the exploration of white matter anisotropy through diffusion tensor imaging, aiding in understanding psychiatric disorders. Advances in technology have expanded its applications to brain development, neurodegeneration, and neurosurgery, emphasizing the importance of model assumptions in interpretation.
Diffusion MRI, tissue microstructure, diffusion tensor imaging, brain imaging
Publication
Acetylcholinesterase Inhibition Reverses Age-Related Pulmonary Decline and Increases Bronchus-Associated Lymphoid Tissue Formation in Aged Mice
Published on 2026-02-03 by Kyle Kenny, Ingrid R. Niesman, Kee S. Moon, Mark Sussman, Morgan K. Wright, Dylan Dawood, Joy A. Phillips @MDPI
Abstract: Age-related chronic, low-grade inflammation, known as inflammaging, contributes to tissue damage and disease. In the lungs, inflammaging leads to abnormal tissue remodeling, reduced function, and decreased immunity. A key factor in inflammaging is declining acetylcholine signaling, which normally suppresses inflammation and promotes tissue repair. We tested whether increasing acetylcholine responsiveness could reverse age-related lung damage. Aged mice were treated with donepezil to increase ace[...]
Our summary: Inhibition of acetylcholinesterase with donepezil reverses age-related lung damage in mice. Treatment improves blood oxygen saturation and voluntary activity while restoring alveolar structure. Increased bronchus-associated lymphoid tissue formation enhances respiratory immunity against infections.
Acetylcholinesterase, Inflammaging, Bronchus-Associated Lymphoid Tissue, Aging
Publication

















